CC vs EW · P/E 72, rev $1.36B vs P/E 47, rev $1.39B
Chemours Co (CC) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CC currently screens at market cap $1.94B and trailing P/E 71.8. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CC and EW stock pages for the full models.
Not investment advice.